Fluoroimmunoassay |
Fluorescein isothiocyanate |
HSA |
0.5 mg/L |
0.5–20 mg/L (linear R2 = 0.99) |
Total time for experiment 4–6 h Recovery 105 ± 7% |
19 Chavers et al., 1984 [113] |
Immunoturbidimetry |
No reagent |
HSA |
4 mg/L |
4–35.5 mg/L (linear) |
Time so screen 15 min Recovery 95%–104% |
20 Lloyd et al., 1987 [114] |
Immunonephelometry |
No reagent |
HSA |
0.34 mg/L |
0.34–43.0 mg/L (detectable) |
Automated version 240 samples an hour CV (intraassay) 6% CV (interassay) 9% |
21 Marre et al., 1987 [115] |
Immunoturbidimetry |
No reagent |
HSA |
2 mg/L |
2–260 mg/L (detectable) |
CV (interassay) 4.8% |
22 Bakker et al., 1988 [116] |
Chemiluminescence |
Acridinium ester |
HSA |
0.01 mg/L |
0.3–10 mg/L (detectable) |
Recovery 90–106% |
23 Horton et al., 1989 [117] |
Radioimmunoassay |
Na125I |
HSA |
0.015 mg/L |
1.18–14.96 mg/L (detectable) |
Recovery 90–106% |
24 Horton et al., 1989 [117] |
Time resolved Fluorescence Resonance Energy Transfer |
Europium chelate (donor)/cyanine 5 (acceptor) |
HSA |
5.5 mg/L |
10–320 mg/L (detectable) |
Experiment time 12 min Recovery 103–122% CV (within-run) 6.9–10% CV (between-run) 7.5–13% |
25 Qin et al., 2003 [118] |
Chemiluminescence enzyme-linked immunosorbent assay based on Avidin–biotin |
4-methoxy4-(3-phosphatephenyl)-spiro-(1,2-dioxetane-3,2 -adamantane) (AMPPD) to detect enzyme activity |
HSA |
0.089 mg/L |
0.15–15 mg/L (linear R2 = 0.9902) |
Low usage of antibody CV (intra-assay) 10.7% CV (inter-assay) 15% Recovery 112% |
26 Zhao et al., 2005 [119] |
Chemiluminescence enzyme-linked immunosorbent assay based on fluorescein-isothiocyanate (FITC) |
4-methoxy4-(3-phosphatephenyl)-spiro-(1,2-dioxetane-3,2 -adamantane) (AMPPD) to detect enzyme activity |
HSA |
0.089 mg/L |
0.15–15 mg/L (linear R2 = 0.9906 |
CV (intra-assay) 10.5% CV (inter-assay) 11.9% Recovery 109% |
27 Zhao et al., 2005 [119] |
Magnetic two-site immunoassay |
Dextran-coated nanoscaled to detect magnetic permeability |
HSA |
5 mg/L |
0–400 mg/L (linear) |
Experiment time 6.5 min CV 11% |
28 Lu et al., 2006 [120] |
Capillary electrophoresis immunoassay with spectrophotometric detection |
Hydroxylamine |
HSA |
0.60 mg/L |
0–6.67 mg/L (detectable) |
Voltage 12 kV Recovey 91–160% |
29 Giovannoli et al., 2007 [66] |
Electrochemical immunosensor |
Fe3O4/Au colloid -modified gold electrode |
NMP22 Nuclear Matrix Protein 22 |
5·10−4 mg/L |
1.2·10−3-0.2 mg/L (linear, R2 = 0.9932) |
CV 3.9% |
30 Ning et al., 2007 [121] |
Resonance scattering (RS) spectral immunoassay |
Cu2O for RS |
HSA |
7.2·10−6 mg/L |
1.4·10−5–4.3·10−4 mg/L |
CV 4.5% Recovery 92.1–106.8% |
31 Jiang et al., 2009 [122] |
Fluoroimmunoassay, a quantum-dot (QS) optical immunosensor (the buffer matrix) |
CdSe/ZnS QS |
HSA |
0.032 mg/L |
0.2–200 mg/L (detectable) |
Low cost immunosensor. |
32 Tu et al., 2012 [123] |
Time-resolved fluorescence resonance energy transfer immunoassay |
Europium based oligonucleotides (donor)/oligonucleotide(acceptor) |
HSA |
0.0039 mg/L |
0.0039–0.5 mg/L (linear) 0.0039–1 mg/L (detectable) |
Experiment time 40 min Tested in serum, salive, urine CV 3% |
33 Wang et al., 2012 [124] |
Chemiluminescence lateral flow immunoassay |
Luminol/enhancer/H2O2 with silicon photosensor |
HSA |
2.5 mg/L |
2.5–850 mg/L (detectable) |
CV 20% Recovery 85–112% |
34 Zangheri et al., 2016 [125] |
Amperometric immunosensor (the buffer matrix) |
Carbon nanotubes/gold nanoparticles screenprinted electrodes |
p53 protein |
6.1·10−4 mg/L |
8.4·10−4-0.437 mg/L (linear) |
CV 10% Recovery 84–144% |
35 Giannetto et al., 2017 [126] |
Piezoelectric immunosensor, label-free immunoassay |
Quartz crystal coated with a silver electrode |
HSA |
0.0095 mg/L |
0.1–100 mg/L |
Diagnostic sensitivity 98.7% Diagnostic specificity 100% |
36 Theansun et al., 2017 [127] |
Time-resolved fluorescence immunoassay |
Europium (III) and samarium (III) |
cystatin-C |
1.26 10−3 mg/L |
0.42 10−3-0.9563 mg/L (linear, R2 = 0.9991) |
Recovery 99.36% CV 3.2–5.9% (inter) CV 3.4–6.3% (intra) |
37 Liu et al., 2017 [128] |
Time-resolved fluorescence immunoassay |
Europium (III) and samarium (III) |
β2-microglobulin |
2.13 10−3 mg/L |
0.86 10−3-0.9754 mg/L (linear, R2 = 0.9998) |
Recovery 100.18% CV 3.0–6.8% (inter) CV 3.1–8.4% (intra) |
38 Liu et al., 2017 [128] |
Chemiluminescence immunoassay |
Magnetic microparticles using carboxylic acid groups, acridinium |
monomeric laminin-γ2 |
1.0 10−5 mg/L |
1.0 10−5-0.02 mg/L (detectable) |
Recovery 82.3–96.2% |
39 Nakagawa et al., 2017 [129] |
Fluoroimmunoassay, optical microchips |
Streptavidin-fusion based variants |
HSA |
0.65 mg/L |
|
Limit of quantification 2 mg/L |
40 Semeradtova et al., 2018 [130] |
Electrochemical ELISA |
Gold sensor chips with a hair comb design |
CFHR1 complement factor H-related 1 |
1.29 10−3 mg/L |
1 10−3-0.01 mg/L (linear) |
|
41 Arya et al., 2018 [131] |
Electrochemical ELISA |
Gold sensor chips with a hair comb design |
NUMA1 nuclear mitotic apparatus protein 1 |
0.97 10−3 mg/L |
1 10−3-0.1 mg/L (linear) |
|
42 Arya et al., 2018 [131] |
Electrochemical immunosensor |
Gold nanoparticles-platinum nanoparticles-metal organic frameworks |
NMP22 nuclear matrix protein 22 |
1.7·10−6 mg/L |
5·10−6-5·10−4 mg/L (linear, R2 = 0.9833) 5·10−4-0.02 mg/L (linear, R2 = 0.9909) |
CV 1.93% Recovery 96%–106% |
43 Zhao et al., 2019 [110] |
Fluoroimmunoassay, graphene oxide-mediated fluorescence quenching aptasensor |
87-nucleotide ssDNA as aptamer |
HSA |
0.05 mg/L |
0.1–14.0 mg/L (detectable) |
Cheap 0.3$ per reaction |
44 Chawjiraphan et al., 2020 [132] |
Enzyme fluroimmunoassay, sandwich-type ultramicroELISA |
4-methylumbelliferil phosphate/diethanolamine-Hcl/sodium azide |
HSA |
1.44·10−3 mg/L |
1.44·10−3-0.2 mg/L (detectable) |
CV 3.98–4.35% (intra) CV 7.59–8.92% (inter) Recovery 94.26–98.50% Time 1.5 h |
45 Valle et al., 2020 [62] |